| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| N-Acetyl Cysteine | Alzheimer's Disease | 3 | PM | 36703196 | 📋 | Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial |
| N-Acetyl Cysteine | Alzheimer's Disease | 2 | PM | 32390631 | 📋 | N-Acetyl Cysteine and Catechin-Derived Polyphenols: A Path Toward Multi-Target Compounds Against Alzheimer's Disease |
| N-Acetyl Cysteine | Alzheimer's Disease | 1 | PM | 30574085 | 📋 | N-Acetylcysteine Prevents the Spatial Memory Deficits and the Redox-Dependent RyR2 Decrease Displayed by an Alzheimer's Disease Rat Model |
| N-Acetyl Cysteine | Demyelinating Disease | 1 | PM | 33954959 | 📋 | N-acetylcysteine protects against cuprizone-induced demyelination: histological and immunohistochemical study |
| N-Acetyl Cysteine | Multiple Sclerosis | 2 | PM | 37386885 | 📋 | Effects of N-acetylcysteine on oxidative stress biomarkers, depression, and anxiety symptoms in patients with multiple sclerosis |
| N-Acetyl Cysteine | Multiple Sclerosis | 1 | PM | 34377857 | 📋 | N-acetyl cysteine administration affects cerebral blood flow as measured by arterial spin labeling MRI in patients with multiple sclerosis |
| N-Acetyl Cysteine | Neurodegenerative Disease | 5 | PM | 35204298 | 📋 | N-Acetyl-Cysteine: Modulating the Cysteine Redox Proteome in Neurodegenerative Diseases |
| N-Acetyl Cysteine | Neurodegenerative Disease | 4 | PM | 34392569 | 📋 | The ameliorative effect of N-acetylcysteine against penconazole induced neurodegenerative and neuroinflammatory disorders in rats |
| N-Acetyl Cysteine | Neurodegenerative Disease | 3 | PM | 32610099 | 📋 | Compounds That Extend Longevity Are Protective in Neurodegenerative Diseases and Provide a Novel Treatment Strategy for These Devastating Disorders |
| N-Acetyl Cysteine | Neurodegenerative Disease | 1 | PM | 31838118 | 📋 | Redox Status, Inflammation, Necroptosis and Inflammasome as Indispensable Contributors to High Fat Diet (HFD)-induced Neurodegeneration; Effect of N-acetylcysteine (NAC) |
| N-Acetyl Cysteine | Neurodegenerative Disease | 2 | PM | 31368586 | 📋 | N-acetylcysteine Alleviated Paraquat-Induced Mitochondrial Fragmentation and Autophagy in Primary Murine Neural Progenitor Cells |
| N-Acetyl Cysteine | Parkinson's Disease | 4 | PM | 37507913 | 📋 | Targeting the Cysteine Redox Proteome in Parkinson's Disease: The Role of Glutathione Precursors and Beyond |
| N-Acetyl Cysteine | Parkinson's Disease | 3 | PM | 37415931 | 📋 | Post-inflammatory administration of N-acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease |
| N-Acetyl Cysteine | Parkinson's Disease | 2 | PM | 37371987 | 📋 | N-Acetylcysteine Treatment May Compensate Motor Impairments through Dopaminergic Transmission Modulation in a Striatal 6-Hydroxydopamine Parkinson's Disease Rat Model |
| N-Acetyl Cysteine | Parkinson's Disease | 1 | PM | 31206613 | 📋 | N-Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease |
